Skip to content

Effects of Virtual Reality Multisensory Cooperative Task-Oriented Mirror Therapy

Virtual Reality Multisensory Cooperative Task-Oriented Mirror Therapy for Neuro-Rehabilitation

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07139379
Enrollment
44
Registered
2025-08-24
Start date
2025-08-20
Completion date
2026-12-31
Last updated
2025-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, Rehabilitation, Virtual Reality, Mirror Movement Therapy, Task Performance

Brief summary

In the proposed study, the investigators assumed that Virtual Reality-Based Generative Bimanual Cooperative Task-Oriented Therapy (VRMCTOMT) will provide a better treatment effects than traditional virtual reality mirror therapy (VRMT) for the patients with unilateral stroke. The aim of the study is to examine the difference in the treatment effects among the combination of task-oriented training with either VRMCTOMT, or VRMT on the upper extremity function and brain activity of the stroke patients.

Interventions

Motor training targeted to goals that are relevant to the functional needs of the patient

Virtual Reality Mirror Therapy using goggle

OTHERVirtual Reality-Based Generative Bimanual Cooperative Task-Oriented Mirror Therapy

Virtual Reality-Based Generative Bimanual Cooperative Task-Oriented Mirror Therapy using goggle

Sponsors

National Cheng-Kung University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Clinical diagnosis of stroke with unilateral side involved; * A score of Mini-mental state examination greater than 24 for proving higher mental function * Time of onset \> 6 months before treatment begins; and * Premorbid right-handedness.

Exclusion criteria

* Severe vision impairment; * Major cognitive-perceptual deficit; * Other brain disease.

Design outcomes

Primary

MeasureTime frameDescription
Change in the result of Fugl-Meyer assessment (FMA) for motor function of upper extremity testbaseline, 9 weeks and 21 weeksEach item is rated on a three-point ordinal scale (2 points for the detail being performed completely, 1 point for the detail being performed partially, and 0 for the detail not being performed). The maximum motor performance score is 66 points for the upper extremity.

Secondary

MeasureTime frameDescription
Change in the result of Modified Ashworth scale (MAS)baseline, 9 weeks and 21 weeksMuscle tone is defined by the resistance of a muscle being stretched without resistance.

Other

MeasureTime frameDescription
Change in the result of Box and blocks testbaseline, 9 weeks and 21 weeksThe score is the number of blocks carried from one box to the other in one minute. Higher values represent a better outcome.
Change in the result of Semmes-Weinstein monofilament (SWM) testbaseline, 9 weeks and 21 weeksThe Semmes-Weinstein monofilamenttest examines the cutaneous pressure threshold, range from 1.65-6.65. Higher values represent a worse outcome.
Change in the result of Motor Activity Logbaseline, 9 weeks and 21 weeksSemi-structured interview examine how much and how well the subject uses their more-affected arm for 30 ADLs. Score range from 0-5. Higher values represent a better outcome.
functional Magnetic Resonance Imagingbaseline, 9 weeksa non-invasive neuroimaging technique that measures brain activity by detecting changes in blood oxygenation (BOLD signal).

Countries

Taiwan

Contacts

Primary ContactHsiu-Yun Hsu, Ph.D
hyhsu@mail.ncku.edu.tw886-6-2353535

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026